^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Undisclosed HER2Bi-armed ATC
i
Other names: Undisclosed HER2Bi-armed ATC, anti-CD3-anti-HER2/neu-activated T cells
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Barbara Ann Karmanos Cancer Institute, TransTarget
Drug class:
HER2 inhibitor, CD3 agonist
Related drugs:
